SecureDX and Panacea Korea enhance animal health

SecureDX, a US-based animal health diagnostics innovator, has announced a strategic partnership with Panacea Korea, a leading South Korean manufacturer of diagnostic testing solutions, to expand access to verified, affordable animal disease testing across North America.

The collaboration brings together advanced diagnostic manufacturing with AI-driven digital reporting to modernise how animal health data is captured, managed, and trusted.

Under the supply and exclusivity agreement, SecureDX will act as Panacea Korea’s exclusive importer and commercialisation partner in North America. The partnership introduces a new portfolio of validated animal disease testing kits and select diagnostic equipment, all integrated with SecureDX’s proprietary SecureOS AI-powered digital reporting and chain-of-custody platform.

The combined offering supports the detection of high-impact infectious diseases, including avian influenza, bovine viral diarrhoea (BVD) and other critical pathogens affecting cattle, swine, poultry, sheep, goats, and exotic or zoo animals. All tests are developed under strict validation and quality management protocols to ensure consistent accuracy across species and testing environments.

A core differentiator of the partnership is the seamless integration of diagnostics with SecureOS. The platform leverages mobile technology and AI-enabled workflow standardisation to streamline sample registration, track chain-of-custody, monitor testing status, and deliver secure, traceable results. This approach reduces manual errors, improves data integrity, and enables standardised reporting for veterinarians, producers, laboratories, and animal health professionals.

Affordability without sacrificing quality is central to the collaboration. Through efficient manufacturing, optimised logistics, and digital workflow automation, SecureDX aims to deliver premium-quality diagnostics at a more accessible price point, expanding reliable testing options for farms, veterinary practices, zoos, laboratories, and animal export operations.

“Accuracy, quality control, and affordability are the foundation of everything we do,” said Justin Jones, CEO of SecureDX. “By combining Panacea Korea’s diagnostic technology with our SecureOSplatform, we are simplifying how testing is performed, reported, and trusted, while keeping costs accessible for real-world animal health applications.”

The partnership will also include PCR instruments and select point-of-care diagnostic platforms, all designed to integrate seamlessly with SecureOS and supported by laboratory validation standards.

“Working with SecureDX allows us to pair high-quality diagnostics with intelligent digital reporting,” said Clara Shin, CEO of Panacea Korea. “Together, we are raising the standard for accurate, affordable, and scalable animal health testing.”

The integrated diagnostic solutions are scheduled to launch in Q1 2026, with tailored offerings for laboratories, commercial farms, veterinary clinics, zoological institutions, and export programmes.